Teva-Triamterene/HCTZ (2020-07-24) Jul 24, 2020 · Published by Health Canada · Official notice
Share
Alert type : Drug Recall
Category : Drugs
Issue : Product Safety
Audience : General Public, Healthcare Professionals, Hospitals
Department : Health Canada
Hazard classification : Type III
Teva-Triamterene/HCTZ
Lot or serial number Companies Brand name DIN, NPN, DIN-HIM Dosage form Strength 35360453A Recalling Firm Teva Canada Limited 30 Novopharm Court Toronto M1B 2K9 Ontario CANADA Marketing Authorization Holder Teva Canada Limited 30 Novopharm Court Toronto M1B 2K9 Ontario CANADA Teva-Triamterene/HCTZ DIN 00532657 Tablet Triamterene 50mg and Hydrochlorothiazide 25mg
The assay for Triamterene is out of specification in the affected lot and the assay for Hydrochlorothiazide (HCTZ) is out of trend in the affected lot. Alternate Brand Names: Maxzide, Dyazide, Dyrenium